Tag:
Congress
Latest Headlines
Latest Headlines
Congressional bills would toughen safety labeling for generic drugmakers
Congressional Democrats are ramping up two bills intended to put generic drugmakers on par with their Big Pharma counterparts as far as governing how they change product labeling to report updated safety information.
FDA builds program for outsourcing foreign plant inspections
The FDA likes the look of a program to outsource inspections, but it's caught in one of those pressure sandwiches between competing congressional concerns.
Lawmakers pressure CMS to get going on doc-disclosure rules
Two senators are pushing regulators to issue rules for complying with the doctor-disclosure provisions of healthcare reform.
Lawmakers push for speedy approvals of 'breakthrough' drugs
Pharmalot has the story of a new proposal from a group of lawmakers calling for faster approval paths for "breakthrough" drugs.
Senator launches campaign for speedier approvals of targeted drugs
In an already politically charged year for the FDA, U.S. Senator Kay Hagan is spearheading legislation that would expedite reviews and approvals of drugs against serious medical conditions, her home...
Obama seeks $156M to boost Alzheimer's research through 2013
Considering that the Obama administration wants to find a way to treat or even wipe out Alzheimer's disease by 2025, at least White House officials are trying to put their money where their mouths
Congresswoman: Novartis troubles call for more FDA oversight
California Congresswoman Mary Bono Mack said she is perplexed that FDA inspectors continued to cite problems at the Novartis ( $NVS ) Lincoln, NE, plant without holding the drugmaker accountable. The...
Bill cites fakes dangers, ups penalties
Increased jail time and financial penalties for drug counterfeiters are the subject of a bill proposed by U.S. legislators. The Counterfeit Drug Penalty Enhancement Act is a bipartisan proposal
Thanks for a miracle in Congress
This year I'm thankful for two things in particular. I'll be remembering them on Thursday, Thanksgiving Day. We won't be publishing that day but will reappear in your inbox next Tuesday, Nov. 29,
Pfizer, J&J among lawmakers' fave drug stocks
There's been a lot of ink spilled recently on congressional representatives and their private investments--and whether rules governing member stock ownership should be changed. If you've been
